Metabolism & Insulin in Neurodegeneration

This feed focuses on the impact of insulin resistance, caloric restriction, cytokine singling, and metabolism on dementia and neurodegenerative diseases.

January 11, 2021

Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps

European Journal of Nuclear Medicine and Molecular Imaging
Silvia Paola CaminitiClara Luigia Gobbo
January 13, 2021
Review
Open Access

Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction

International Journal of Molecular Sciences
Thomas M BarberMartin O Weickert
January 14, 2021

Endocrine dysfunction and cognitive impairment

Minerva endocrinologica
Valeria CalsolaroFabio Monzani
January 9, 2021
Review
Open Access

Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration

Molecular Neurobiology
Mahsa DolatshahiMohammad Hadi Aarabi
January 10, 2021

Biliary diversion increases resting energy expenditure leading to decreased blood glucose level in mice with type 2 diabetes

Journal of Diabetes Investigation
Haixin YinXiaodong He
January 12, 2021
Review

So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis

Journal of Internal Medicine
A SchäbitzN Garzorz-Stark
January 9, 2021
Open Access

Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro

Fluids and Barriers of the CNS
Snehal RautAbraham J Al-Ahmad
January 13, 2021
Open Access

Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases

Neural Regeneration Research
Isaac G OnyangoGorazd B Stokin
January 13, 2021

Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins

Advances in Experimental Medicine and Biology
Emanuele Buratti
January 14, 2021
Open Access

Adipocytes and macrophages secretomes coregulate catecholamine-synthesizing enzymes

International Journal of Medical Sciences
Andreia GomesLaura Ribeiro
January 13, 2021

Salvia Miltiorrhiza in Anti-diabetic Angiopathy

Current Molecular Pharmacology
Zequn YinJihong Han
January 13, 2021

α-Synuclein and neuronal membranes: conformational flexibilities in health and disease

Chemistry and Physics of Lipids
José Carlos BozelliRichard M Epand
January 12, 2021
Review
Open Access

Does Diet Have a Role in the Treatment of Alzheimer's Disease?

Frontiers in Aging Neuroscience
Mitchell Thelen, Holly M Brown-Borg
January 9, 2021
Preprint
Open Access

Double stranded RNA drives innate immune responses, sickness behavior and cognitive impairment dependent on dsRNA length, IFNAR1 expression and age

BioRxiv : the Preprint Server for Biology
N. McGarryColm Cunningham
January 9, 2021

Peroxisomal Dysfunction and Oxidative Stress in Neurodegenerative Disease: A Bidirectional Crosstalk

Advances in Experimental Medicine and Biology
Marc FransenPaul P Van Veldhoven

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/dementia-neurodegenerative-diseases/d57ab6a4-aabc-444f-9d59-10f4318bed7a